Delivery Order SPE2DB22D2009-SPE2DB23FM0DK
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Albuterol HFA 90 MCG Inhaler 8.5GM. The contract has a ceiling value of $1,124.96 and a completion date of May 2, 2023. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This contract award, valued at $2,515.87, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of albuterol HFA 90 mcg inhalers. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,605.96 delivery order is for the supply of Albuterol HFA 90 MCG inhalers, with an ultimate completion date of November 15, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This single-award IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,884.32 Firm Fixed Price Delivery Order is for the supply of Albuterol HFA 90mcg inhalers to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,905.04 delivery order contract is for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, a critical respiratory medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp's parent company, Cencora, Inc., with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of Albuterol HFA 90 MCG inhalers to the Defense Logistics Agency (DLA). The $7,140.17 firm fixed-price delivery order has a completion date of September 12, 2023 and is not associated with any set-aside requirements. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,668.89, is a Firm Fixed Price Delivery Order for the supply of Albuterol HFA 90 MCG Inhalers. The contract has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,193.56 Firm Fixed Price Delivery Order contract is for the supply of 4566873689 ALBUTEROL HFA 90 MCG INHALER 8.5GM. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,556,138,924 units of Albuterol HFA 90 MCG Inhaler 8.5GM. The $8,560.86 firm fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (doing business as Amerisourcebergen) holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- This federal contract award, valued at $1,162.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albuterol HFA 90 MCG Inhaler 8.5GM, a critical medical commodity used in various healthcare settings. The contract has an ultimate completion date of March 17, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB23FM0DKDelivery Order
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a $2,394.95 Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, a critical pharmaceutical product, to support military healthcare programs. This award is part of Amerisourcebergen's broader $999,999,999 IDC with the DLA, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense globally. Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contracts demonstrate Amerisourcebergen's significant role as a key supplier of essential pharmaceuticals and medical commodities to various federal government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 4/21/23 |